Scott Dreyer
Corporate Officer/Principal presso COLLEGIUM PHARMACEUTICAL, INC.
Patrimonio netto: 1 M $ in data 31/03/2024
Posizioni attive di Scott Dreyer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Corporate Officer/Principal | 10/07/2018 | - |
| Sales & Marketing | 01/01/2018 | 10/07/2018 |
Storia della carriera di Scott Dreyer
Precedenti posizioni note di Scott Dreyer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| THE MEDICINES COMPANY | Sales & Marketing | 01/09/2016 | 01/12/2017 |
| BIOGEN INC. | Sales & Marketing | 01/06/2014 | 01/09/2016 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/1994 | 01/01/2013 |
Formazione di Scott Dreyer
| University of Messiah | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Sales & Marketing | 3 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
- Borsa valori
- Insiders
- Scott Dreyer
- Esperienza
